The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Perceived weight discrimination partially mediated the association between high BMI and future pain in middle-aged and older adults.

New Mexico[US], February 1 (ANI): People receiving haemodialysis for kidney failure frequently feel chronic pain associated with their disease, which can be difficult to manage with opioid medication ...

Gas prices could surge as much as 50 cents per gallon in the Midwest, as Canada and Mexico supply more than 70 percent [PDF] of crude oil imports to U.S. refineries. Also at risk are cars and ...

New Delhi: With Finance Minister Nirmala Sitharaman set to present the Union Budget 2025 in just a few hours, Editor (Politics) DK Singh, Deputy Editor TCA Sharad Raghavan, and Deputy editor Moushumi ...

Have you been paying attention to current events recently? See how many of these 10 questions you can get right. Compiled by Jeremy Engle Is there a goal you’d like to pursue by doing ...